COMMUNIQUÉS West-GlobeNewswire

BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025
02/12/2025
MENLO PARK, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced [...]
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization
02/12/2025
SHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“ BGLC ” or the “ Company ”), an emerging provider of precision oncology diagnostics with expanding operations across Southeast Asia, today [...]
First U.S. Commercial Sale of KOMZIFTI™ Triggers $135 Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin
02/12/2025
SAN DIEGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA, “Kura”), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced [...]
DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio
02/12/2025
DNA-based Colorectal Cancer Screening as a Home Test BERKELEY, Calif. and MAINZ, Germany, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company“), molecular genetics [...]
Amneal to Participate in Upcoming Investor Conferences
02/12/2025
BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that Chirag Patel, Co-Chief Executive and President, and Tasos Konidaris, Chief Financial Officer, will [...]
Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer
02/12/2025
Positive feedback reinforces Silexion’s trajectory toward its planned Phase 2/3 trial initiation in Q2 2026 Company plans to complete regulatory submissions to the Israeli Ministry of Health by the end of Q4 2025 and in [...]
Genvor and Tuskegee University Announce Teaming Agreement to Advance Peptide Research and Sustainable Crop Protection Technologies
02/12/2025
Woodland, CA, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTC: GNVR), a pioneer in AI-accelerated peptide technology for sustainable agriculture, today announced it has entered into a formal teaming agreement with [...]
Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs
02/12/2025
AGOURA HILLS, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano , a clinical-stage nanomedicine company, today announced new data demonstrating that [...]
Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
02/12/2025
DURHAM, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos [...]
Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology
02/12/2025
— New Peer-Reviewed Publication Highlights Phase 2 SPRING Trial Data Supporting the Disease Modifying Potential of Nebokitug in PSC and Supports Advancement to a P hase 3 Registration Trial — TEL AVIV, Israel, Dec. 02, [...]
AnewHealth Names Ken Burdick Chairman of Board of Directors
02/12/2025
With decades of experience and expertise in healthcare, Burdick will support AnewHealth in a strategic capacity as the organization advances on its mission of delivering transformative pharmacy solutions CLEVELAND, OH [...]
HealthLynked Expands Board of Directors With Addition of Two Leading Insurance Executives: Chris G. Pulos of Marsh McLennan and Jason Bishara of NSI Insurance
02/12/2025
NAPLES, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK ), an AI-driven global healthcare network focused on improving care coordination and reducing healthcare costs, today announced [...]
Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.
02/12/2025
Proven commercial leader with 20+ years of experience driving revenue growth and market adoption for early-stage and high-growth MedTech companies Strong track record of launching breakthrough technologies across spine [...]
Alberta Cancer Foundation launches 'The Time Store' campaign to bring more moments to Albertans facing cancer
02/12/2025
Province-wide campaign asks Albertans to give more meaningful moments for people like patient Colin Dalziel EDMONTON, Alberta, Dec. 02, 2025 (GLOBE NEWSWIRE) -- This Giving Tuesday and throughout the holiday season, [...]
The Ensign Group Adds Real Estate and Operations in Kansas
02/12/2025
SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Increases Operations in Arizona
02/12/2025
SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Grows Operations in Colorado
02/12/2025
SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Tacalyx Appoints Jean Engela as Chief Executive Officer to Spearhead Next Phase of Growth
02/12/2025
Berlin, Germany, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Tacalyx, a privately held biotech company focused on developing novel TACA (Tumour Associated Carbohydrate Antigens) cancer therapies, announces the appointment of Jean [...]
Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions
02/12/2025
The collaboration unites complementary scientific and technical expertise to provide seamless solutions across the biopharmaceutical value chain Clients to benefit from accelerated timelines, as well as reduced [...]

Pages